Form 4: European Wax Center CEO Awarded Stock and Options
SEC Form 4 Filing
European Wax Center's CEO, Christopher Daniel Morris, received 600,000 shares of restricted stock and options to purchase 1,650,000 shares of Class A Common Stock.
Summary
- Christopher Daniel Morris, CEO of European Wax Center, was granted 600,000 shares of Class A Common Stock on January 8, 2025.
- These shares are restricted and will vest in four equal annual installments starting January 8, 2026, contingent on continued employment.
- Mr. Morris also received options to purchase 1,650,000 shares of Class A Common Stock.
- The options are divided into three tranches: 800,000 at an exercise price of $6.41, 425,000 at $9, and 425,000 at $12.
- These options will become fully vested and exercisable on January 8, 2029, also subject to continued employment.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative surprises or concerns.
Positives
- The grant of stock and options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule for both the stock and options encourages long-term commitment from the CEO.
- The options provide an incentive for the CEO to increase the company's share price.
Risks
- The vesting of the stock and options is contingent on the CEO's continued employment, which could be a risk if he were to leave the company.
- The value of the options is dependent on the future performance of the company's stock price.
Industry Context
This type of equity-based compensation is common for CEOs in publicly traded companies to align their interests with shareholders and incentivize long-term growth.
Comparison to Industry Standards
- Equity grants and stock options are a standard component of executive compensation packages in publicly traded companies.
- The vesting schedules and exercise prices are typical for such grants, designed to incentivize long-term performance and retention.
- Companies like Ulta Beauty and Sally Beauty also use similar compensation structures for their executives.
Stakeholder Impact
- Shareholders may view this positively as it aligns the CEO's interests with the company's long-term performance.
- Employees may see this as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 01/08/2025 | Date of the stock and option grants. |
| 01/08/2026 | Start date for the annual vesting of the restricted stock. |
| 01/08/2029 | Date when the stock options become fully vested and exercisable. |
| 01/08/2035 | Expiration date for the stock options. |
| 01/10/2025 | Date the form was signed. |
Keywords
stock options, restricted stock, executive compensation, CEO, equity, EWCZ, European Wax Center
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.